(LEVI) Levi Strauss - Overview
Stock: Jeans, Tops, Footwear, Accessories
| Risk 5d forecast | |
|---|---|
| Volatility | 34.9% |
| Relative Tail Risk | -9.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.69 |
| Alpha | 8.20 |
| Character TTM | |
|---|---|
| Beta | 1.478 |
| Beta Downside | 1.518 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.47% |
| CAGR/Max DD | 0.23 |
EPS (Earnings per Share)
Revenue
Description: LEVI Levi Strauss January 06, 2026
Levi Strauss & Co. (NYSE: LEVI) designs, markets, and sells a full-line apparel portfolio-including jeans, casual and dress pants, active-wear, tops, outerwear, footwear, and accessories-under the Levi’s, Dockers, Signature, Denizen, and Beyond Yoga brands. The company reaches consumers through a mix of third-party retailers (department stores, specialty chains, e-commerce platforms, franchisees) and its own channels (company-operated mainline and outlet stores, e-commerce sites, and brand-dedicated shop-in-shops). It also licenses the Levi’s and Dockers trademarks for categories such as belts, wallets, bags, and hosiery.
Key recent metrics: FY 2023 revenue was $7.6 billion, with a 9 % year-over-year increase in direct-to-consumer (DTC) sales, now representing roughly 35 % of total revenue. Inventory turnover improved to 4.2 ×, reflecting tighter supply-chain management, while the company’s adjusted EBITDA margin expanded to 12.5 % as cost-saving initiatives took hold. Macro-level drivers include U.S. consumer discretionary spending trends, inflation-adjusted pricing power in the premium denim segment, and the broader shift toward sustainable, “made-in-America” apparel that aligns with Levi’s “Water For a deeper quantitative view of LEVI’s valuation and risk profile, you might explore the analyst tools on ValueRay to complement this overview.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 578.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -5.79 > 1.0 |
| NWC/Revenue: 17.85% < 20% (prev 13.57%; Δ 4.28% < -1%) |
| CFO/TA 0.08 > 3% & CFO 545.7m > Net Income 578.1m |
| Net Debt (1.55b) to EBITDA (888.9m): 1.74 < 3 |
| Current Ratio: 1.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (397.2m) vs 12m ago -1.29% < -2% |
| Gross Margin: 61.73% > 18% (prev 0.60%; Δ 6113 % > 0.5%) |
| Asset Turnover: 95.01% > 50% (prev 97.18%; Δ -2.17% > 0%) |
| Interest Coverage Ratio: 14.05 > 6 (EBITDA TTM 888.9m / Interest Expense TTM 48.6m) |
Altman Z'' 3.01
| A: 0.16 (Total Current Assets 3.15b - Total Current Liabilities 2.03b) / Total Assets 6.85b |
| B: 0.28 (Retained Earnings 1.90b / Total Assets 6.85b) |
| C: 0.10 (EBIT TTM 682.6m / Avg Total Assets 6.61b) |
| D: 0.33 (Book Value of Equity 1.49b / Total Liabilities 4.57b) |
| Altman-Z'' Score: 3.01 = A |
Beneish M -2.98
| DSRI: 1.08 (Receivables 774.7m/710.0m, Revenue 6.28b/6.20b) |
| GMI: 0.98 (GM 61.73% / 60.36%) |
| AQI: 0.98 (AQ_t 0.27 / AQ_t-1 0.28) |
| SGI: 1.01 (Revenue 6.28b / 6.20b) |
| TATA: 0.00 (NI 578.1m - CFO 545.7m) / TA 6.85b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of LEVI shares?
Over the past week, the price has changed by +9.90%, over one month by +2.35%, over three months by +0.66% and over the past year by +28.06%.
Is LEVI a buy, sell or hold?
- StrongBuy: 7
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LEVI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27 | 24.1% |
| Analysts Target Price | 27 | 24.1% |
| ValueRay Target Price | 23.1 | 6.2% |
LEVI Fundamental Data Overview February 13, 2026
P/E Forward = 15.2672
P/S = 1.3724
P/B = 3.7803
Revenue TTM = 6.28b USD
EBIT TTM = 682.6m USD
EBITDA TTM = 888.9m USD
Long Term Debt = 1.04b USD (from longTermDebt, last quarter)
Short Term Debt = 260.7m USD (from shortTermDebt, last quarter)
Debt = 2.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 10.08b USD (8.62b + Debt 2.31b - CCE 848.8m)
Interest Coverage Ratio = 14.05 (Ebit TTM 682.6m / Interest Expense TTM 48.6m)
EV/FCF = 31.08x (Enterprise Value 10.08b / FCF TTM 324.3m)
FCF Yield = 3.22% (FCF TTM 324.3m / Enterprise Value 10.08b)
FCF Margin = 5.16% (FCF TTM 324.3m / Revenue TTM 6.28b)
Net Margin = 9.20% (Net Income TTM 578.1m / Revenue TTM 6.28b)
Gross Margin = 61.73% ((Revenue TTM 6.28b - Cost of Revenue TTM 2.40b) / Revenue TTM)
Gross Margin QoQ = 60.75% (prev 61.66%)
Tobins Q-Ratio = 1.47 (Enterprise Value 10.08b / Total Assets 6.85b)
Interest Expense / Debt = 0.58% (Interest Expense 13.4m / Debt 2.31b)
Taxrate = 19.38% (38.5m / 198.7m)
NOPAT = 550.3m (EBIT 682.6m * (1 - 19.38%))
Current Ratio = 1.55 (Total Current Assets 3.15b / Total Current Liabilities 2.03b)
Debt / Equity = 1.01 (Debt 2.31b / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = 1.74 (Net Debt 1.55b / EBITDA 888.9m)
Debt / FCF = 4.77 (Net Debt 1.55b / FCF TTM 324.3m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.74% (Net Income 578.1m / Total Assets 6.85b)
RoE = 27.00% (Net Income TTM 578.1m / Total Stockholder Equity 2.14b)
RoCE = 21.46% (EBIT 682.6m / Capital Employed (Equity 2.14b + L.T.Debt 1.04b))
RoIC = 17.35% (NOPAT 550.3m / Invested Capital 3.17b)
WACC = 9.06% (E(8.62b)/V(10.93b) * Re(11.36%) + D(2.31b)/V(10.93b) * Rd(0.58%) * (1-Tc(0.19)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.55%
[DCF Debug] Terminal Value 65.56% ; FCFF base≈462.9m ; Y1≈303.9m ; Y5≈138.7m
Fair Price DCF = 7.15 (EV 2.29b - Net Debt 1.55b = Equity 741.4m / Shares 103.7m; r=9.06% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 3.24 | EPS CAGR: -3.02% | SUE: 0.69 | # QB: 0
Revenue Correlation: 17.10 | Revenue CAGR: 2.81% | SUE: 0.75 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.23 | Chg30d=+0.003 | Revisions Net=-3 | Analysts=15
EPS current Year (2026-11-30): EPS=1.47 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+9.9% | Growth Revenue=+5.9%
EPS next Year (2027-11-30): EPS=1.65 | Chg30d=-0.003 | Revisions Net=+4 | Growth EPS=+11.8% | Growth Revenue=+4.9%